A tradition of innovation
EDAP TMS: History and Innovations in treatment of prostate cancer and urinary tract stones
Since it was founded in 1979, EDAP TMS has been committed to introducing new and innovative technologies for a minimally-invasive approach to treating urological disorders. These proprietary technologies such as Focused Ultrasound or Piezo-electric shock waves have yielded new minimally invasive procedures for the treatment of several pathologies such as benign prostatic hyperplasia, localized prostate cancer or urinary tract stones. EDAP TMS' design philosophy is to develop minimally-invasive devices for the benefit of the patient associating treatment efficacy and safety. The strength of EDAP TMS Research and Development activity is to master mechanical, acoustic, electronic and IT technologies to produce state-of-the-art and ergonomic medical devices.
History & Innovations
EDAP TMS products are alternatives to traditional surgical procedures which often involve high costs, significant side effects and long recovery times. Founded in 1979, the Company EDAP originally specialized in the manufacturing and distribution of ultrasound scanners and produced the first piezo-electric lithotripter in 1985. Following a merger with Technomed International S.A. in 1994, EDAP TMS launched various generations of lithotripters, urological laser and Prostate Hyperplasia treatment devices (Prostatron) using TUMT (TransUrethral Microwave Therapy) while developing HIFU technology to treat Prostate Cancer.
40 years of innovation in non-invasive Therapies
By constantly investing in R&D, and by partnering with renowned medical research institutions (basic research and clinical research) EDAP TMS has developed a large patent portfolio based on its innovative technologies. The company annually invests 10% of its revenues in Research & Development activities (R&D) to maintain and strengthen its level of innovation and research. EDAP TMS develops innovate projects with the financial support of institutional partners such as, Agence National de la Recherche, BPI France, the DIRECCTE, the Grand Lyon, the Auvergne Rhône-Alpes Region.
HIFU innovations and patents
2013 - Focal One
2005 - Ablatherm HIFU Integrated Imaging
2000 - Ablapak
1999-2000 - CE Mark
1999 - Ablasonic
1996 - Ablatherm Multicenter clinical trial
1994 - Patient protection
1993 - First prostate cancer treatment
1991 - Ablatherm
1989 - HIFU technology
ESWL innovations and patents
2019 Endo-UP Complet Stone Platform
The platform was designed to allow the surgeon to perform simulated percutaneous and ureteroscopic procedures. It also allows a single surgeon to perform a parallel endoscopic procedure coupled with an LEC.